Daptomycin

NDC 70594-053 · Xellia Pharmaceuticals USA LLC

Generic nameDaptomycin

Dosage formINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

RouteINTRAVENOUS

Active ingredient(s)DAPTOMYCIN

Strength350 mg/7mL

Pharmacologic classLipopeptide Antibacterial [EPC], Lipopeptides [CS]

Marketing categoryNDA

Packages

70594-053-01 — 1 VIAL, SINGLE-USE in 1 CARTON (70594-053-01) / 7 mL in 1 VIAL, SINGLE-USE

J0873 — Injection, daptomycin (xellia), not therapeutically equivalent to j0878 or j0872, 1 mg Medicare Part B payment limit (ASP + 6%): $0.04

FDA lists these products with the same active ingredient.

60977-145 — daptomycin, 63323-371 — Daptomycin, 67184-0549 — Daptomycin, 67457-813 — daptomycin, 67457-941 — daptomycin, 68001-376 — Daptomycin, 70377-093 — Daptomycin, 70436-033 — daptomycin, 70511-182 — Daptomycin, 70594-034 — Daptomycin, 70594-060 — daptomycin, 70594-066 — daptomycin, 71288-016 — DAPTOMYCIN, 71288-017 — DAPTOMYCIN, 71839-107 — daptomycin, 71839-108 — daptomycin, 72572-100 — Daptomycin, 72572-102 — Daptomycin, 72572-158 — daptomycin, 72603-147 — Daptomycin, +25 more

From the FDA National Drug Code Directory, retrieved 2026-08-24. Product listings are submitted by labelers; FDA does not verify them.